• 2 hours Could China Start Dumping U.S. Treasury Bonds?
  • 18 hours Is Winter Coming For HBO?
  • 24 hours Rise Of EVs Signals Peak Gasoline
  • 2 days Jeff Bezos Doubles Down On Space Colonization Ambitions
  • 2 days Gold Mining Stocks Stuck In Limbo
  • 3 days Executive Order Targets Huawei Over Espionage
  • 3 days Why Now May Be The Best Time Ever To Hold Gold
  • 4 days Fake News Sinks Shares In UK-Based Bank
  • 4 days De Beers To Build $468 Million Diamond Recovery Ship
  • 4 days Moody's: Turkey Faces Possible Credit Downgrade
  • 4 days Tesla's Solar Sales Are Slipping
  • 5 days Auto Industry To Get Temporary Tariff Relief
  • 5 days Welcome To The World’s Biggest Free Trade Area
  • 5 days Central Banks Are Stockpiling Gold At The Fastest Rate In Half A Decade
  • 5 days U.S.-China Impasse Threatens Rare Earth Trade
  • 6 days Wall Street Bears $1 Trillion Brunt Of Trade War
  • 6 days Mobile Sports Betting Isn’t Quite Minting Millionaires Just Yet
  • 6 days The Marijuana Industry’s Shocking Secret
  • 6 days A Generational Shift Is Quietly Unfolding In The Mining Industry
  • 7 days Pentagon To Pay $6 Billion To Help Build Border Wall
How Millennials Are Reshaping Real Estate

How Millennials Are Reshaping Real Estate

The real estate market is…

Market Sentiment At Its Lowest In 10 Months

Market Sentiment At Its Lowest In 10 Months

Stocks sold off last week…

Mark Valek

Mark Valek

Mark is founding partner and investment manager of Incrementum AG. Together with Ronald Stoeferle he manages a global macro fund, which is based on the…

Contact Author

Ronald-Peter Stoferle

Ronald-Peter Stoferle

Incrementum AG

Ronald, born 1980 in Vienna, Austria, is a Chartered Market Technician (CMT) and a Certified Financial Technician (CFTe). During his studies in business administration and…

Contact Author

  1. Home
  2. Markets
  3. Other

In Gold We Trust 2016 - Compact Version

Gold is back! With the strongest quarterly performance in 30 years, the precious metal in Q1 2016 emerged from the bear market that had been in force since 2013. A decisive factor in this comeback is growing uncertainty over the recovery of the post-Lehman economy. After years of administering high doses of monetary painkillers, will the Fed succeed in discontinuing the practice? Or is the entire therapy about to be fundamentally questioned?

In Gold We Trust 2016 - Compact Version

The extended version is available at http://www.incrementum.li/en/research-analysis/in-gold-we-trust-2016/

 

Read the Report

Back to homepage

Leave a comment

Leave a comment